Pretransplant Cardiac Evaluation Using Novel Technology
Hematopoietic stem-cell transplantation (HSCT) is a complex procedure that has been increasingly successful in treating malignant and nonmalignant conditions. Despite its effectiveness, it can be associated with potentially life-threatening adverse effects. New onset heart failure, ischemic disease,...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/8/5/690 |
id |
doaj-b675a2cec8184f4590bfd08c2bdbc614 |
---|---|
record_format |
Article |
spelling |
doaj-b675a2cec8184f4590bfd08c2bdbc6142020-11-25T01:31:22ZengMDPI AGJournal of Clinical Medicine2077-03832019-05-018569010.3390/jcm8050690jcm8050690Pretransplant Cardiac Evaluation Using Novel TechnologyMohamad Hemu0Allison Zimmerman1Dinesh Kalra2Tochukwu Okwuosa3Department of Medicine, Rush University Medical Center, Chicago, IL 60612, USADepartment of Medicine, Rush University Medical Center, Chicago, IL 60612, USADepartment of Medicine, Rush University Medical Center, Chicago, IL 60612, USADepartment of Medicine, Rush University Medical Center, Chicago, IL 60612, USAHematopoietic stem-cell transplantation (HSCT) is a complex procedure that has been increasingly successful in treating malignant and nonmalignant conditions. Despite its effectiveness, it can be associated with potentially life-threatening adverse effects. New onset heart failure, ischemic disease, and arrhythmias are among the most notable cardiovascular complications post-HSCT. As a result, appropriate cardiac risk stratification prior to transplant could result in decreased morbidity and mortality by identifying patients with a higher probability of tolerating possible toxicities associated with HSCT. In this review, we aim to discuss the utility of cardiac screening using novel modalities of imaging technology in the pre-HSCT phase.https://www.mdpi.com/2077-0383/8/5/690hematopoietic stem cell transplantcardiac imagingcardiovascular complicationsechocardiogramcardiac magnetic resonancespeckle tracking echocardiographycoronary computed tomography |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mohamad Hemu Allison Zimmerman Dinesh Kalra Tochukwu Okwuosa |
spellingShingle |
Mohamad Hemu Allison Zimmerman Dinesh Kalra Tochukwu Okwuosa Pretransplant Cardiac Evaluation Using Novel Technology Journal of Clinical Medicine hematopoietic stem cell transplant cardiac imaging cardiovascular complications echocardiogram cardiac magnetic resonance speckle tracking echocardiography coronary computed tomography |
author_facet |
Mohamad Hemu Allison Zimmerman Dinesh Kalra Tochukwu Okwuosa |
author_sort |
Mohamad Hemu |
title |
Pretransplant Cardiac Evaluation Using Novel Technology |
title_short |
Pretransplant Cardiac Evaluation Using Novel Technology |
title_full |
Pretransplant Cardiac Evaluation Using Novel Technology |
title_fullStr |
Pretransplant Cardiac Evaluation Using Novel Technology |
title_full_unstemmed |
Pretransplant Cardiac Evaluation Using Novel Technology |
title_sort |
pretransplant cardiac evaluation using novel technology |
publisher |
MDPI AG |
series |
Journal of Clinical Medicine |
issn |
2077-0383 |
publishDate |
2019-05-01 |
description |
Hematopoietic stem-cell transplantation (HSCT) is a complex procedure that has been increasingly successful in treating malignant and nonmalignant conditions. Despite its effectiveness, it can be associated with potentially life-threatening adverse effects. New onset heart failure, ischemic disease, and arrhythmias are among the most notable cardiovascular complications post-HSCT. As a result, appropriate cardiac risk stratification prior to transplant could result in decreased morbidity and mortality by identifying patients with a higher probability of tolerating possible toxicities associated with HSCT. In this review, we aim to discuss the utility of cardiac screening using novel modalities of imaging technology in the pre-HSCT phase. |
topic |
hematopoietic stem cell transplant cardiac imaging cardiovascular complications echocardiogram cardiac magnetic resonance speckle tracking echocardiography coronary computed tomography |
url |
https://www.mdpi.com/2077-0383/8/5/690 |
work_keys_str_mv |
AT mohamadhemu pretransplantcardiacevaluationusingnoveltechnology AT allisonzimmerman pretransplantcardiacevaluationusingnoveltechnology AT dineshkalra pretransplantcardiacevaluationusingnoveltechnology AT tochukwuokwuosa pretransplantcardiacevaluationusingnoveltechnology |
_version_ |
1725087027528990720 |